Protein and Peptide Nanoparticles for Drug Delivery

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

• Protein- and Peptide-Drug Conjugates: An Emerging Drug Delivery TechnologyImran Vhora, Sushilkumar Patil, Priyanka Bhatt and Ambikanandan MisraModifications of Natural Peptides for Nanoparticle and Drug DesignAndrew P. Jallouk, Rohun U. Palekar, Hua Pan, Paul H. Schlesinger and Samuel A. WicklineHybrid Protein–Synthetic Polymer Nanoparticles for Drug DeliveryNeli S. Koseva1, Joanna Rydz, Ekaterina V. Stoyanova and Violeta A. Mitova Efficient Delivery of Therapeutic Agents by Using Targeted Albumin NanoparticlesHasan Kouchakzadeh, Maryam Sadat Safavi and Seyed Abbas ShojaosadatiVasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug DeliveryRebecca Klippstein and David PozoImplications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer DrugsAhmed. O. Elzoghby, Mayada. M. Elgohary and Nayra M. KamelPolysaccharide Nanoparticles for Protein and Peptide Delivery: Exploring Less-Known MaterialsMarlise Araújo dos Santos and Ana GrenhaBioconjugation of Silk Fibroin Nanoparticles with Enzyme and Peptide and Their Characterization  Fei Wang and Yu-Qing ZhangFood-Grade Protein-Based Nanoparticles and Microparticles for Bioactive Delivery: Fabrication, Characterization, and UtilizationGabriel Davidov-Pardo, Iris J. Joye and David Julian McClements